Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wojciech Łuczaj, Ewa Gindzienska-Sieskiewicz, Iwona Jarocka-Karpowicz, Luka Andrisic, Stanisław Sierakowski, Neven Zarkovic, Georg Waeg & Elżbieta Skrzydlewska. (2016) The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radical Research 50:3, pages 304-313.
Read now
Read now
Articles from other publishers (22)
Wonsuk Choi, Ji-Hyoun Kang, Ji Yong Park, A Ram Hong, Jee Hee Yoon, Hee Kyung Kim & Ho-Cheol Kang. (2023) Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naïve rheumatoid arthritis patients: A nationwide cohort study. Seminars in Arthritis and Rheumatism 63, pages 152274.
Crossref
Crossref
Jiahui Yan, Sisi Yang, Liang Han, Xin Ba, Pan Shen, Weiji Lin, Tingting Li, Ruiyuan Zhang, Ying Huang, Yao Huang, Kai Qin, Yu Wang, Shenghao Tu & Zhe Chen. (2023) Dyslipidemia in rheumatoid arthritis: the possible mechanisms. Frontiers in Immunology 14.
Crossref
Crossref
G. V. Papamichail, T. E. Markatseli, A. N. Georgiadis, V. G. Xydis, H. Milionis, A. A. Drosos & P. V. Voulgari. (2022) The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study. Heart and Vessels 37:12, pages 2128-2136.
Crossref
Crossref
O. A. Fomicheva, T. V. Popkova, L. B. Krougly, E. V. Gerasimova, D. S. Novikova, O. A. Pogorelova, M. I. Tripoten, T. V. Balakhonova, Yu. A. Karpov & E. L. Nasonov. (2021) Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis. Kardiologiia 61:1, pages 12-21.
Crossref
Crossref
Rabia Agca, Luuk H.G.A. Hopman, Koen J.C. Laan, Vokko P. van Halm, Mike J.L. Peters, Yvo M. Smulders, Jacqueline M. Dekker, Giel Nijpels, Coen D.A. Stehouwer, Alexandre E. Voskuyl, Maarten Boers, Willem F. Lems & Michael T. Nurmohamed. (2020) Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study. The Journal of Rheumatology 47:3, pages 316-324.
Crossref
Crossref
Alexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, Jacqueline Capeau, Stéphanie Rouanet, Jean Sibilia, Philippe Ravaud, Francis Berenbaum, Jacques-Eric Gottenberg & Jérémie Sellam. (2019) Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. RMD Open 5:2, pages e000897.
Crossref
Crossref
Theodosios D. Filippatos, Angelos Liontos, Eliza C. Christopoulou & Moses S. Elisaf. (2019) Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects. Current Vascular Pharmacology 17:4, pages 332-340.
Crossref
Crossref
D.M. Schulte, K. Paulsen, K. Türk, B. Brandt, S. Freitag-Wolf, I. Hagen, R. Zeuner, J.O. Schröder, W. Lieb, A. Franke, S. Nikolaus, U. Mrowietz, S. Gerdes, S. Schreiber & M. Laudes. (2018) Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutrition, Metabolism and Cardiovascular Diseases 28:11, pages 1100-1105.
Crossref
Crossref
T. V. Popkova & D. S. Novikova. (2018) ACCORDING TO THE MATERIALS OF THE 2015/2016 NEW EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) GUIDELINES FOR REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY ARTHRITIS: GENERAL CHARACTERIZATION AND DISCUSSION PROBLEMS. Rheumatology Science and Practice 56:3, pages 272-279.
Crossref
Crossref
Aikaterini Arida, Athanasios Protogerou, George Kitas & Petros Sfikakis. (2018) Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. International Journal of Molecular Sciences 19:7, pages 1890.
Crossref
Crossref
Theodosios D. Filippatos, Anastazia Kei, Christos V. Rizos & Moses S. Elisaf. (2017) Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables. Journal of Cardiovascular Pharmacology and Therapeutics 23:1, pages 3-12.
Crossref
Crossref
Hiba AbouAssi, Margery A. Connelly, Lori A. Bateman, K. Noelle Tune, Janet L. Huebner, Virginia B. Kraus, Deborah A. Winegar, James D. Otvos, William E. Kraus & Kim M. Huffman. (2017) Does a lack of physical activity explain the rheumatoid arthritis lipid profile?. Lipids in Health and Disease 16:1.
Crossref
Crossref
Roberta Gualtierotti, Nicola Ughi, Giovanni Marfia & Francesca Ingegnoli. (2017) Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis. Rheumatology and Therapy 4:2, pages 293-308.
Crossref
Crossref
Vivek Kumar, Jaya Prakash, Ajai Kumar, Baishnab C. Tripathy, Varsha Gupta & Mohammad Yahiya Khan. (2017) Methotrexate as effective and safe choice for the treatment of rheumatoid arthritis. Current Orthopaedic Practice 28:4, pages 430-435.
Crossref
Crossref
Arduino A Mangoni, Angelo Zinellu, Salvatore Sotgia, Ciriaco Carru & Gian Luca Erre. (2017) Methotrexate and Cardiovascular Protection: Current Evidence and Future Directions. Clinical Medicine Insights: Therapeutics 9, pages 1179559X1774128.
Crossref
Crossref
R Agca, S C Heslinga, S Rollefstad, M Heslinga, I B McInnes, M J L Peters, T K Kvien, M Dougados, H Radner, F Atzeni, J Primdahl, A Södergren, S Wallberg Jonsson, J van Rompay, C Zabalan, T R Pedersen, L Jacobsson, K de Vlam, M A Gonzalez-Gay, A G Semb, G D Kitas, Y M Smulders, Z Szekanecz, N Sattar, D P M Symmons & M T Nurmohamed. (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the Rheumatic Diseases 76:1, pages 17-28.
Crossref
Crossref
Gerhard W. Naerr, Philipp Rein, Christoph H. Saely & Heinz Drexel. (2016) Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis. Vascular Pharmacology 81, pages 22-30.
Crossref
Crossref
Nicoletta Ronda, Daniela Greco, Maria Pia Adorni, Francesca Zimetti, Elda Favari, Gunnbjørg Hjeltnes, Knut Mikkelsen, Maria Orietta Borghi, Ennio Giulio Favalli, Rita Gatti, Ivana Hollan, Pier Luigi Meroni & Franco Bernini. (2015) Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism. Arthritis & Rheumatology 67:5, pages 1155-1164.
Crossref
Crossref
Sipahee Lal Patel, Vivek Kumar, Rachana Mishra, Vishal Chandra, Mahendra P.S. Negi, Baishnab C. Tripathy, Jaya Prakash & Varsha Gupta. (2015) Effectiveness of methotrexate therapy with occasional corticosteroid in rheumatoid arthritis. Current Orthopaedic Practice 26:2, pages 148-154.
Crossref
Crossref
György Kerekes, Michael T. Nurmohamed, Miguel A. González-Gay, Ildikó Seres, György Paragh, Zsófia Kardos, Zsuzsa Baráth, László Tamási, Pál Soltész & Zoltán Szekanecz. (2014) Rheumatoid arthritis and metabolic syndrome. Nature Reviews Rheumatology 10:11, pages 691-696.
Crossref
Crossref
Shi‐Cun Wang, Qiang Xie & Wei‐Fu LV. (2014) Positron emission tomography/computed tomography imaging and rheumatoid arthritis. International Journal of Rheumatic Diseases 17:3, pages 248-255.
Crossref
Crossref
Theodosios D. Filippatos, Evangelos C. Rizos, Vasilios Tsimihodimos, Irene F. Gazi, Alexandros D. Tselepis & Moses S. Elisaf. (2013) Small High-Density Lipoprotein (HDL) Subclasses are Increased with Decreased Activity of HDL-Associated Phospholipase A2 in Subjects with Prediabetes. Lipids 48:6, pages 547-555.
Crossref
Crossref